Table 6.
Characteristics of advanced thymic carcinoma patients administered first‐line treatment
| Variable | N (n = 17) | % |
|---|---|---|
| Gender | ||
| Male | 12 | 70.6 |
| Female | 5 | 29.4 |
| Age, years | ||
| < 60 | 13 | 76.5 |
| ≥ 60 | 4 | 23.5 |
| ECOG PS | ||
| 0 | 9 | 52.9 |
| 1 | 8 | 47.1 |
| CD8+ | ||
| Low | 7 | 41.2 |
| High | 10 | 58.8 |
| PD‐L1 | ||
| Low | 5 | 29.4 |
| High | 12 | 70.6 |
| TGF‐β | ||
| Low | 5 | 29.4 |
| High | 12 | 70.6 |
| First‐line chemo best response | ||
| PR | 4 | 23.5 |
| SD | 13 | 76.5 |
| RT after first‐line chemo | ||
| − | 8 | 47.1 |
| + | 9 | 52.9 |
Chemo, chemotherapy; ECOG PS, Eastern Cooperative Oncology Group performance status; PR, partial response; RT, radiotherapy; SD, stable disease; TGF‐β, transforming growth factor‐β.